Safety of and antibody response to the BNT162b2 COVID-19 vaccine in adolescents and young adults with underlying disease.
Shoji K, Funaki T, Yamada M, Mikami M, Miyake K, Ueno S, Tao C, Myojin S, Aiba H, Matsui T, Ogimi C, Kato H, Miyairi I.
Shoji K, et al. Among authors: miyairi i.
J Infect Chemother. 2023 Jan;29(1):61-66. doi: 10.1016/j.jiac.2022.09.013. Epub 2022 Sep 21.
J Infect Chemother. 2023.
PMID: 36152928
Free PMC article.